Skip to main content
. 2020 Apr 3;11:400. doi: 10.3389/fphar.2020.00400

Table 4.

The indirect meta-analysis of the 6MW, PAP, and CI for ambrisentan versus bosentan, ambrisentan versus sildenafil, bosentan versus sildenafil by software STATA.

Exponential Statistic OR CIs (95%) Chi2 P
6MW A vs B 0.112 0 2933.422 0.178 0.673
A vs S 0 0 5.437 2.6 0.107
B vs S 0.003 0 60.005 1.294 0.255
PAP A vs B 2.466 0 2.99E+08 0.009 0.924
A vs S 0.513 0 20323.13 0.015 0.902
B vs S 1.077 0 40807.864 0 0.989
CI A vs B 1.208 0 1.60E+36 0 0.996
A vs S 0.985 0.272 3.566 0.001 0.982
B vs S 0.988 0 0.274 1.27 0.985
HHS Vulnerability Disclosure